China Universal Asset Management Co., Ltd.

Position in CCCC — C4 Therapeutics, Inc.

CIK 1906594 SHANGHAI, F4

Position in CCCC

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$82,177

+$36,636 QoQ

Shares Held

17,597

+1.6% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#108

of 147 holders

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

China Universal Asset Management Co., Ltd. holds $180,189,557 across 240 Biotechnology names. CCCC ranks #177 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	48,265	$23,974,673
2	REGN	Regeneron Pharmaceuticals, Inc.	19,498	$12,157,782
3	ALNY	Alnylam Pharmaceuticals, Inc.	25,269	$7,606,727
4	RPRX	Royalty Pharma plc	120,547	$6,759,070
5	RVMD	Revolution Medicines, Inc.	33,835	$6,336,618
6	IONS	Ionis Pharmaceuticals Inc	76,302	$6,049,985
7	MRNA	Moderna, Inc.	63,149	$4,422,324
8	ARGX	Argenx SE	4,642	$4,306,708

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$82,177	17,597	+1.6%	Shares	Sole	2026-07-24
2026-03-31	$45,541	17,316	+9.7%	Shares	Sole	2026-04-28
2025-12-31	$30,162	15,792	+26.6%	Shares	Sole	2026-01-29
2025-09-30	$27,694	12,475	-12.5%	Shares	Sole	2025-11-10
2025-06-30	$20,393	14,261	+0.2%	Shares	Sole	2025-08-28
2025-03-31	$22,782	14,239	-4.9%	Shares	Sole	2025-04-30
2024-12-31	$53,881	14,967	+1079.4%	Shares	Sole	2025-01-24
2023-09-30	$2,360	1,269	+97.4%	Shares	Sole	2024-05-22
2023-06-30	$1,768	643	-3.3%	Shares	Sole	2024-05-22
2023-03-31	$2,088	665	+33.8%	Shares	Sole	2024-05-22
2022-12-31	$2,932	497	+8.5%	Shares	Sole	2024-05-22
2022-09-30	$4,016	458	—	Shares	Sole	2022-10-21
No filing history on record for this holder in this stock.